Fig.Infectious Disease Testing Market Projection
Infectious diseases are disorders caused by organisms such as bacteria, viruses, fungi or parasites. Many organisms live in and on our bodies. They're normally harmless or even helpful, but under certain conditions, some organisms may cause disease. Some infectious diseases can be passed from person to person. Some are diffused by bites from insects or animals. And others are acquired by feeding contaminated food or water or being exposed to organisms in the environment. Signs and symptoms vary depending on the organism causing the infection, but often include fever and fatigue. Mild infections may respond to rest and home remedies, while some life-threatening infections may require hospitalization. Many infectious diseases, such as measles and chickenpox, can be prevented by vaccines. Early diagnosis and treatment of these infectious diseases will play a crucial role in avoiding long-term complications. Molecular testing, microbiology and immunodiagnostics are the key diagnosis methods available.
Rise in base of geriatric population, increasing awareness among the population about communicable diseases, reducing immunity levels, growing prevalence of infectious diseases and rise in demand for point of care diagnostics are the key driving factors for the growth of this market. In addition, increased adoption of advanced technologies, shifting healthcare trend towards more precise, safer and effective diagnosis and advances in molecular biology are creating lucrative growth opportunities in the coming years. The market for global infectious disease testing was valued at USD billion 17.0 billion in 2015 and is expected to reach around USD 31.8 billion by 2022, growing at a CAGR of 8.4% during the forecast period of 2016 to 2022. However, there are certain restraining factors which could hamper the growth of the market, which includes complex regulatory framework for the approval of new diagnostic tests.
Geographically, North America is leading contributor to the market and is expected to retain its position during the forecast period due to the presence of sophisticated healthcare infrastructure and rigorous R&D activities by the market players in this region. Nonetheless, the market for Asia-Pacific region is expected to grow at a faster rate owing to changing lifestyle habits, rising prevalence of infectious diseases, growing healthcare spending and favorable reimbursement policies.
The report delivers a strategic analysis of the global market for infectious diseases and growth forecast for the period from 2016 – 2022. The scope of the report includes competitive analysis of various market players who are operating in the market, segmental analysis based on type of technology, products and applications, . It also covers geographical analysis of the market with growth forecast for the period of 2016 – 2022. The Porter’s Five Forces analysis and value chain analysis included in the report provides an insight into market dynamics and industry competition.
The study also provides information for recent merger and acquisition deals happened in the global infectious disease market. Moreover, the report also includes growth strategies and entry barriers to be considered to cater to the exact business opportunities in this market. Additionally, to aid in strategic decision making, the report also includes competitive profiling of leading players, recent developments in the industry and various business strategies adopted by them. This report will help players in global infectious disease testing market to plan and implement their strategies in different market areas such as emerging geographies, and new technologies
1 Scope of the report
1.1 Report description
1.2 Research methodology
1.3 List of abbreviations
1.4 Market segmentation
2 Executive summary
3 Qualitative analysis
3.1 Market overview
3.2 Porters five forces analysis
3.3 Key M&A trends and strategic partnerships
3.4 Competitive matrix of the key companies
4 Global infectious disease testing market, by technology, 2014 - 2022
4.1 Molecular testing
5 Global infectious disease testing market, by product, 2014 - 2022
6 Global infectious disease testing market, by application, 2014 - 2022
6.3 Methicillin-resistant Staphylococcus Aureus (MRSA) infection
6.4 Human papillomavirus (HPV)
6.5 Respiratory tract infections
7 Global infectious disease testing market, by geography, 2014 - 2022
7.1 North America
7.4 Rest of the World
8 Company profiles
8.1 Abbott Laboratories
8.2 Becton, Dickinson & Co.
8.3 Bio-Rad Laboratories
8.4 Thermo Fisher Scientific, Inc.
8.5 Siemens Healthcare
8.6 Roche Diagnostics
8.7 Gen-Probe, Inc. (a part of Hologic, Inc.)
8.8 Johnson and Johnson
8.9 bioMeriux SA